Stryker (SYK) Gains from Investment Securities (2009 - 2026)
Stryker (SYK) reported Gains from Investment Securities of -$1.0 million for Q1 2026, down 105.0% year-over-year from $20.0 million in Q1 2025, and down 100.1% quarter-over-quarter from $961.0 million in Q4 2025.
Stryker (SYK) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Stryker (SYK) has 14 years of Gains from Investment Securities data on file, last reported at -$1.0 million in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at -$1.0 million, down 105.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $981.0 million (up 356.28% YoY), and the FY2025 annual result was $1.0 billion, up 413.85% from the prior year.
- Gains from Investment Securities fell to -$1.0 million in Q1 2026 per SYK's latest filing, from $961.0 million in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $961.0 million in Q4 2025 and troughed at -$124.0 million in Q4 2023.
- A 5-year average of $106.1 million and a median of $14.5 million in 2022 frame the typical range for Gains from Investment Securities.
- On a YoY basis, Gains from Investment Securities climbed as much as 1128.57% in 2022 and fell as far as 750.0% in 2022.
- A 5-year view of Gains from Investment Securities shows it stood at $512.0 million in 2022, then plunged by 124.22% to -$124.0 million in 2023, then surged by 291.13% to $237.0 million in 2024, then jumped by 305.49% to $961.0 million in 2025, then slumped by 100.1% to -$1.0 million in 2026.
- Business Quant data shows SYK's Gains from Investment Securities at -$1.0 million in Q1 2026, $961.0 million in Q4 2025, and -$74.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Dec 31, 2025 | 961.00 Mn |
| Dec 31, 2025 | 961.00 Mn |
| Sep 30, 2025 | -74.00 Mn |
| Sep 30, 2025 | -74.00 Mn |
| Jun 30, 2025 | 95.00 Mn |
| Jun 30, 2025 | 95.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Dec 31, 2024 | 237.00 Mn |
| Dec 31, 2024 | 237.00 Mn |
| Sep 30, 2024 | -12.00 Mn |
| Sep 30, 2024 | -12.00 Mn |
| Jun 30, 2024 | -30.00 Mn |
| Jun 30, 2024 | -30.00 Mn |
| Dec 31, 2023 | -124.00 Mn |
| Dec 31, 2023 | -124.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |